The latest UK biotech financing report, published by the BioIndustry Association (BIA)

With the Chancellor’s plans to develop Europe’s SiliconValley between Oxford and Cambridge, the future looks bright for UKbiotech. It’s inspiring to see the sector thriving, and we look forward to the groundbreaking research and innovation that will continue to strengthen its position on the global stage.

“At Cambridge Innovation Capital, we invest in disruptive companies from the Cambridge ecosystem, building world-class businesses based on exceptional innovation. As early-stage investors with a maturing portfolio, we are cautiously optimistic about the growing pool of capital for biotech, particularly with increased access to pension funds, which could provide vital funding for UK biotech companies to support their growth.” 

 – Anne Horgan, Partner, Cambridge Innovation Capital